{"symbol":"JNJ","fiscalQuarter":"Q3-2011","reportDate":"2011-10-18","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2011","postBrief":{"headline":"Johnson & Johnson Misses on EPS \u2014 Stock Up 0.99%","keyNumbers":[{"metric":"EPS","actual":"$1.15","expected":"N/A","surprise":"-4.80%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management emphasized their commitment to long-term growth despite the EPS miss.","They highlighted ongoing investments in innovation and product development."],"summary":"Overall, management remains focused on strategic initiatives to drive future performance. They acknowledged the challenges faced in the quarter but expressed confidence in their long-term vision."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"The earnings report indicates that Johnson & Johnson's EPS fell short of expectations, which could raise concerns among investors. However, the stock reacted positively, rising by nearly 1%. This suggests that investors may be looking beyond the EPS miss, focusing instead on the company's long-term growth strategy and commitment to innovation.","metaDescription":"Johnson & Johnson (JNJ) Q3 2011 earnings: EPS missed expectations. Stock up 0.99%. Full breakdown."}}